# EDGAR Filing Document

**Accession Number:** 0001443533
**File Stem:** 0001641172-25-014511
**Filing Date:** 2025-6
**Character Count:** 7078
**Document Hash:** 54cf2d9dad79d93b6c4d8cca0bb43c35
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-014511.hdr.sgml**: 20250610

**ACCESSION NUMBER**: 0001641172-25-014511

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250609

**FILED AS OF DATE**: 20250610

**DATE AS OF CHANGE**: 20250610

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Davis Jason
- **CENTRAL INDEX KEY:** 0001443533

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41934
- **FILM NUMBER:** 251037005

**MAIL ADDRESS:**
- **STREET 1:** 27003 BARRINGTON LODGE LN
- **CITY:** KATY
- **STATE:** TX
- **ZIP:** 77494
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FibroBiologics, Inc.
- **CENTRAL INDEX KEY:** 0001958777
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 863329066
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 455 E. MEDICAL CENTER BLVD
- **STREET 2:** SUITE 300
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77598
- **BUSINESS PHONE:** 281-671-5150

**MAIL ADDRESS:**
- **STREET 1:** 455 E. MEDICAL CENTER BLVD SUITE 300
- **STREET 2:** SUITE 300
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77598

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FibroBiologics Inc.
- **DATE OF NAME CHANGE:** 20221216

## Ex-24

**Exhibit 24**

**Limited Power of Attorney**

The undersigned, Jason D. Davis, understands that, from time to time, they are required to prepare, execute and file certain federal and state securities laws filings.

The undersigned hereby appoints and authorizes each of Ruben A. Garcia, General Counsel of FibroBiologics Inc., and Pete O'Heeron, Chief Executive Officer of FibroBiologics Inc., as the undersigned's true and lawful attorney-in-fact, each with full power of substitution and full power to act alone, to:

(1) prepare
 and sign in the name of and on behalf of the undersigned any and all forms and reports required
 to be filed pursuant to the Exchange Act of 1933 and the Securities Exchange Act of 1934
 and the rules and regulations thereunder, including, but without limitation, Forms 3, 4 and
 5 and Schedule 13D/G;

(2) perform
 any and all acts for and on behalf of the undersigned which may be necessary or desirable
 to complete and execute any such forms and filings, and timely file such forms with the United
 States Securities and Exchange Commission; and

(3) take
 any other action of any type in connection with the foregoing which, in the opinion of the
 attorney-in-fact, may be of benefit to, in the best interest of, or legally required by,
 the undersigned, it being understood that the documents executed by such attorney-in-fact
 on behalf of the undersigned pursuant to this Limited Power of Attorney shall be in such
 form and shall contain such terms and conditions as such attorney-in-fact may approve in
 such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever required, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution (including appointing substitutes for themselves, for each other and for any successor to any attorney-in-fact hereunder) or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.

This Limited Power of Attorney shall remain in effect until the undersigned is no longer required to file forms with respect to the securities of FibroBiologics, Inc., unless earlier revoked by the undersigned in a signed and dated writing delivered to the foregoing attorney-in-fact.

Executed this 9th day of June, 2025.

---

| |
|:---|
| /s/ Jason D. Davis |
| Jason D. Davis |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Davis Jason<br><sub>(Last) (First) (Middle)</sub><br>C/O FIBROBIOLOGICS, INC.<br>455 E. MEDICAL CENTER BLVD., SUITE 300<br><sub>(Street)</sub><br>HOUSTON,, TX 77598<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>FibroBiologics, Inc. [ FBLG ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-06-09 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Financial Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

**Remarks:**
Exhibit 24 Power of Attorney

**Signature:** /s/ Ruben A. Garcia, by Power of Attorney  
**Date:** 2025-06-10

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**